CURIS, INC. Fair Value Adjustment of Warrants
CURIS, INC. (CRIS) reported Fair Value Adjustment of Warrants of -$1.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- CURIS, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$1.30M.
- CURIS, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $12.76M.
- CURIS, INC. fair value adjustment of warrants for the quarter ending 2025-06-30 was $0.00.
- CURIS, INC. fair value adjustment of warrants for the quarter ending 2025-03-31 was $0.00.
- CURIS, INC. fair value adjustment of warrants for fiscal 2016 was $0.00.
- CURIS, INC. fair value adjustment of warrants for fiscal 2015 was $0.00.
- CURIS, INC. fair value adjustment of warrants for fiscal 2014 was -$717.00K.
- CURIS, INC. fair value adjustment of warrants for fiscal 2013 was -$771.39K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.30M 10-Q · filed 2026-08-14 | $11.46M 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $12.76M 10-Q · filed 2026-05-13 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | ||||
| 2016-12-31 | $0.00 10-K · filed 2017-03-09 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $0.00 derived: sum of 2 quarters · filed 2017-03-09 | $0.00 derived: sum of 3 quarters · filed 2017-03-09 | $0.00 10-K · filed 2017-03-09 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | |||
| 2014-12-31 | -$214.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$68.12K derived: sum of 2 quarters · filed 2017-03-09 | -$625.38K derived: sum of 3 quarters · filed 2017-03-09 | -$717.00K 10-K · filed 2017-03-09 | -$716.79K 10-K · filed 2015-02-24 |
| 2014-09-30 | -$67.91K 10-Q · filed 2015-11-09 | -$625.16K derived: sum of 2 quarters · filed 2015-11-09 | -$716.79K 10-Q · filed 2015-11-09 | -$1.93M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$557.25K 10-Q · filed 2015-08-06 | -$648.88K 10-Q · filed 2015-08-06 | -$1.86M derived: sum of 3 quarters · filed 2016-02-29 | -$785.87K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$91.62K 10-Q · filed 2015-05-07 | -$1.30M derived: sum of 2 quarters · filed 2016-02-29 | -$228.62K derived: sum of 3 quarters · filed 2016-02-29 | -$561.76K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$136.99K derived: sum of 2 quarters · filed 2016-02-29 | -$470.13K derived: sum of 3 quarters · filed 2016-02-29 | -$771.39K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $1.07M 10-Q · filed 2014-11-10 | $739.55K derived: sum of 2 quarters · filed 2014-11-10 | $438.29K 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | -$333.14K 10-Q · filed 2014-08-07 | -$634.40K 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | -$301.26K 10-Q · filed 2014-05-09 | ||||
| 2012-12-31 | -$2.26M 10-K · filed 2015-02-24 | ||||
| 2011-12-31 | $2.76M 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |